"This panel will provide an overview of the economics and financial environment of the Japanese pharmaceutical environment, consolidation trends and the critical dimensions of planning and executing partnerships and alliances with Japanese pharmaceutical and biotech companies. Japanese-American collaboration has re-emerged as an essential strategy for companies from both countries for product development, clinical and regulatory affairs and marketing. Over the last two decades many of these relationships have enjoyed noteworthy success, but many problems have been cited in the formation and execution as well. A review of specific recent case studies will highlight trends for collaboration."

Objective1:Outline the major challenges in establishing and executing relationships between Japanese and non-Japanese companies.

Objective2:Discuss the varieties of relationships that are being structured and why.

Objective3:Present case study examples and lessons learned.